Annual Global Summit for Precision Diagnosis of Prostate Cancer
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Boston Business Journal chose AdMeTech President and CEO Dr. Faina Shtern as one of the Women of Influence
Women of Influence: AdMeTech Foundation Chief Faina Shtern takes on prostate cancer. After she emigrated from the Soviet Union as a Jewish refugee escaping oppression, Faina Shtern knew what she wanted to do once she landed in America in the late 1970s: medical research.
With a medical degree from Chemovets Medical School in the Ukraine, Shtern proceeded to pursue her dream, eventually working at a number of prestigious institutions over the years, including being appointed a clinical and research fellow at Massachusetts General Hospital and Harvard Medical School, where she subsequently became a faculty member.
Leading Experts Release Cutting-Edge Information on Prostate Cancer Screening
FOR IMMEDIATE RELEASE Contact: Christopher Pond christopher.pond@admetechfoundation.org 857-301-0189 LEADING EXPERTS RELEASE CUTTING-EDGE INFORMATION ON PROSTATE CANCER SCREENING Men are Encouraged to Know Risk Level Indicators, Talk to Their Doctors and Make Fully-Informed and Shared Decisions Analysis to be Detailed at 8th Annual Prostate Cancer Awareness Day at State House Boston, MA, March 23, 2016.…
Fewer Men Are Getting Prostate Cancer Blood Tests, And That May Not Be a Good Thing
Fewer Men Are Getting Prostate Cancer Blood Tests, And That May Not Be a Good Thing Some experts now advise men not to get the blood test that can pick up prostate cancer, but that may be putting certain men at risk Health advice is often confusing — and conflicting — and nothing proves that…
Studies Find Declines in Screening and Early Detection of Prostate Cancer
Studies Find Declines in Screening and Early Detection of Prostate Cancer By DENISE GRADYNOV. 17, 2015 Fewer men are being screened for prostate cancer, and fewer early-stage cases are being detected, according to two studies published Tuesday in the Journal of the American Medical Association. The number of cases has dropped not because the disease…
Groundbreaking work on prostate cancer genetics
[heading title_size=”title-size-small” text_align=”center” text_color_custom=”#ffffff” icon_type=”noicon” icon_size=”32″ icon_color=”#de5034″ icon_style=”circle” icon_color_bg=”#ffffff” icon_color_border=”#dbdbdb” icon_border_size=”1″ icon_border_radius=”500″ icon_border_spacing=”50″]Groundbreaking work on prostate cancer genetics[/heading] National Cancer Institute and National Genome Project announced that the Cancer Genome Atlas (TCGA) Research Network produced groundbreaking results in research on genetic alterations in prostate cancer. These findings identified seven drivers of of prostate cancer, which…
Federal US PSTF Task Force is updating its recommendation against PSA screening
Federal US PSTF Task Force is updating its recommendation against PSA screening From AdMeTech Foundation – November 3, 2015 The U.S. Preventive Services Task Force (USPSTF) announced on October 29, 2015 that it will re-evaluate and update its recommendation against PSA screening for prostate cancer made in 2011-2012. Read more In October 2011, AdMeTech…
ONE YEAR OUT: Boston Non-Profit Kicks Off Plans for First-Ever Global Summit on New, Precision Diagnostics for Prostate Cancer
FOR IMMEDIATE RELEASE Media Contact: Kate Lagreca kate@northwindstrategies.com ONE YEAR OUT: Boston Non-Profit Kicks Off Plans for First-Ever Global Summit on New, Precision Diagnostics for Prostate Cancer BOSTON, MA, October 20, 2015—AdMeTech Foundation today hosted a kick-off breakfast to launch the first-ever Global Summit on Diagnostic Solutions for Prostate Cancer Care, which is planned…
Reduced prostate screening could miss advanced tumors
Reduced prostate screening could miss advanced tumors By STEVEN REINBERG September 24, 2015, 8:30 AM Relaxed guidelines on prostate cancer screening may delay diagnosis and treatment of aggressive tumors, a new study suggests. In 2011, the U.S. Preventive Services Task Force recommended against routine prostate specific antigen (PSA) testing,…
NAACP’S NEW ENGLAND AREA CONFERENCE DELEGATES LEARN ABOUT PROSTATE CANCER AS A LEADING HEALTH CARE DISPARITY IN BLACK MEN
NEWS ADVISORY Media Contact: Kate Lagreca Kate@northwindstrategies.com NAACP’S NEW ENGLAND AREA CONFERENCE DELEGATES LEARN ABOUT PROSTATE CANCER AS A LEADING HEALTH CARE DISPARITY IN BLACK MEN NEAC NAACP Features AdMeTech Foundation’s Workshop on The Cutting-Edge Advances in Early Detection and Treatment BEDFORD, MA—September 24, 2015—Juan Cofield, President of the New England Area Conference…